Page last updated: 2024-09-03

rb 101 and 1-hydroxy-3-amino-2-pyrrolidone

rb 101 has been researched along with 1-hydroxy-3-amino-2-pyrrolidone in 1 studies

Compound Research Comparison

Studies
(rb 101)
Trials
(rb 101)
Recent Studies (post-2010)
(rb 101)
Studies
(1-hydroxy-3-amino-2-pyrrolidone)
Trials
(1-hydroxy-3-amino-2-pyrrolidone)
Recent Studies (post-2010) (1-hydroxy-3-amino-2-pyrrolidone)
570219809

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besson, JM; Buritova, J; FourniƩ-Zaluski, MC; Le Guen, S; Roques, BP1

Other Studies

1 other study(ies) available for rb 101 and 1-hydroxy-3-amino-2-pyrrolidone

ArticleYear
Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
    European journal of pain (London, England), 2003, Volume: 7, Issue:3

    Topics: Analgesics; Animals; Carrageenan; Disulfides; Drug Therapy, Combination; Enkephalins; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Immunohistochemistry; Inflammation; Male; Naloxone; Narcotic Antagonists; Pain; Phenylalanine; Proto-Oncogene Proteins c-fos; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord

2003